[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367710-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-367710-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","associations-between-blood-metabolite-levels-and-gastrointestinal-cancer-risk-a-preliminary-untargeted-metabolomics-study","Associations between blood metabolite levels and gastrointestinal cancer risk: A preliminary untargeted metabolomics study","","Gastrointestinal cancers are among the most commonly diagnosed cancers globally, and traditional Chinese medicine (TCM) is used for prevention and treatment. This study investigated the metabolic basis of a common TCM syndrome in gastrointestinal cancers, focusing on underlying metabolic mechanisms and candidate metabolic biomarkers. Thirty healthy controls, and 30 gastric cancer and 30 colorectal cancer patients were profiled by gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry with pathway enrichment analysis. Distinct metabolomic alterations were identified, including hundreds of differentially expressed metabolites and shared metabolites enriched in multiple pathways, supporting PXYD syndrome-related metabolic characteristics and biomarker potential.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/associations-between-blood-metabolite-levels-and-gastrointestinal-cancer-risk-a-preliminary-untargeted-metabolomics-study/367710/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/associations-between-blood-metabolite-levels-and-gastrointestinal-cancer-risk-a-preliminary-untargeted-metabolomics-study/367710.png","ImageObject",300,407,{"name":42,"@type":43},"Stanley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",20,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study aim regarding TCM syndrome and gastrointestinal cancers?","Question",{"text":63,"@type":64},"To investigate the metabolic basis of a common TCM syndrome in gastrointestinal cancers, exploring underlying metabolic mechanisms and identifying potential metabolic biomarkers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were participants selected and what platforms were used for metabolomics detection?",{"text":68,"@type":64},"The study enrolled 30 healthy controls, 30 gastric cancer patients, and 30 colorectal cancer patients in 2023. Plasma metabolite profiles were detected using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry.",{"name":70,"@type":61,"acceptedAnswer":71},"What key metabolomics findings were reported for gastric and colorectal cancers?",{"text":72,"@type":64},"CRC and GC samples showed large numbers of differentially expressed metabolites, along with 352 shared metabolites across gastrointestinal cancers. Enrichment analysis linked shared metabolites to 10 metabolic pathways.",{"name":74,"@type":61,"acceptedAnswer":75},"What conclusion did the study reach about PXYD syndrome in gastrointestinal cancers?",{"text":76,"@type":64},"The study revealed metabolomic characteristics consistent with spleen deficiency and blood stasis toxin (PXYD) syndrome to some extent, providing rationale for the “same treatment for different diseases” approach and supporting potential metabolomics-based biomarkers.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},367710,1790378534,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":55,"slug":122},9,"Religion & Spirituality","religion-spirituality",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":108,"preview_page_count":33,"preview_urls":148},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","| W | J | G | O | World Journal of\u003Cbr>Gastrointestinal Oncology |\n| --- | --- | --- | --- | --- |\n\nSubmit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com) World J Gastrointest Oncol 2025 July 15; 17(7): 104860  \nDOI: 10.4251/wjgo.v17.i7.104860 ISSN 1948-5204 (online)  \nORIGINAL ARTICLE  \nBasic Study  \nAssociations between blood metabolite levels and gastrointestinal cancer risk: A preliminary untargeted metabolomics study  \nTian-Hao Guo, Wen-Jian Zhu, Yi-Fan Hui, Shuo-Qi Zhao, Ting-Ting Zhou, Xue-Meng Wang, Qin-Chang Zhang, Wei Wang, Liu Li, Wei-Xing Shen, Xiao-Yu Wu, Hai-Bo Cheng  \nSpecialty type: Oncology  \nProvenance and peer review:  \nUnsolicited article; Externally peer reviewed.  \nPeer-review model: Single blind  \nPeer-review report’s classification Scientific Quality: Grade A, Grade B  \nNovelty: Grade B, Grade B  \nCreativity or Innovation: Grade B, Grade B  \nScientific Significance: Grade B, Grade B  \nP-Reviewer: Fan XC  \nReceived: January 6, 2025  \nRevised: April 24, 2025  \nAccepted: June 6, 2025  \nPublished online: July 15, 2025  \nProcessing time: 191 Days and 16.7 Hours  \nTian-Hao Guo, Institute of Health and Regimen, Jiangsu Open University, Nanjing 210036, Jiangsu Province, China  \nTian-Hao Guo, Yi-Fan Hui, Shuo-Qi Zhao, Xue-Meng Wang, Qin-Chang Zhang, Liu Li, Wei-Xing Shen, Hai-Bo Cheng, The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu Province, China  \nTian-Hao Guo, Hai-Bo Cheng, Department of Oncology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu Province, China  \nWen-Jian Zhu, Department of Oncology, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210017, Jiangsu Province, China  \nTing-Ting Zhou, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China  \nWei Wang, OE Biotech Co., Ltd., Shanghai 201112, China  \nXiao-Yu Wu, Department of Surgical Oncology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu Province, China  \nCo-first authors: Tian-Hao Guo and Wen-Jian Zhu.  \nCo-corresponding authors: Xiao-Yu Wu and Hai-Bo Cheng.  \nCorresponding author: Hai-Bo Cheng, PhD, Chief Physician, Professor, The First Clinical Medical College, Nanjing University of Chinese Medicine, No. 138 Xianlin Road, Nanjing 210023, Jiangsu Province, [China.](China. 2068324936@qq.com)[ 2068324936@qq.com](China. 2068324936@qq.com)  \nAbstract  \nBACKGROUND  \nGastrointestinal cancers are among the most commonly diagnosed cancers globally. Traditional Chinese medicine (TCM) offers distinct advantages in preventing and treating these cancers.  \nAIM  \nTo investigate the metabolic basis of a common TCM syndrome in gastrointestinal cancers, exploring underlying metabolic mechanisms and identifying potential  \n WJGO  [https://www.wjgnet.com](https://www.wjgnet.com) 1 July 15, 2025  Volume 17  Issue 7   \nGuo TH et al. Associations between metabolites and gastrointestinal cancer  \nbiomarkers.  \nMETHODS  \nThirty healthy controls (normal group), 30 patients with gastric cancer (GC), and 30 patients with colorectal cancer (CRC) were enrolled in 2023. Plasma metabolic profiles were detected using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry, and pathway enrichment analysis was conducted using the Kyoto Encyclopedia of Genes and Genomes.  \nRESULTS  \nMetabolic profiling revealed distinct alterations in gastrointestinal cancers. CRC samples exhibited 455 differentially expressed metabolites (234 upregulated and 221 downregulated) . Similarly, GC samples exhibited 459 differentially expressed metabolites (251 upregulated and 208 downregulated) . Additionally, 352 shared metabolites were identified among gastrointestinal cancers. Enrichment analysis highlighted the involvement of these shared metabolites in 10 metabolic pathways.  \nCONCLUSION  \nTo some extent, this study revealed the metabolomic charac","cbCaikb06FnMBsyr","https://ap.wps.com/l/cbCaikb06FnMBsyr","pdf",38600771,"English","# Abstract\n## Background\n## Aim\n## Methods\n## Results\n## Conclusion\n# Core Tip\n# Citation\n# Keywords","[{\"question\":\"What was the study aim regarding TCM syndrome and gastrointestinal cancers?\",\"answer\":\"To investigate the metabolic basis of a common TCM syndrome in gastrointestinal cancers, exploring underlying metabolic mechanisms and identifying potential metabolic biomarkers.\"},{\"question\":\"How were participants selected and what platforms were used for metabolomics detection?\",\"answer\":\"The study enrolled 30 healthy controls, 30 gastric cancer patients, and 30 colorectal cancer patients in 2023. Plasma metabolite profiles were detected using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry.\"},{\"question\":\"What key metabolomics findings were reported for gastric and colorectal cancers?\",\"answer\":\"CRC and GC samples showed large numbers of differentially expressed metabolites, along with 352 shared metabolites across gastrointestinal cancers. Enrichment analysis linked shared metabolites to 10 metabolic pathways.\"},{\"question\":\"What conclusion did the study reach about PXYD syndrome in gastrointestinal cancers?\",\"answer\":\"The study revealed metabolomic characteristics consistent with spleen deficiency and blood stasis toxin (PXYD) syndrome to some extent, providing rationale for the “same treatment for different diseases” approach and supporting potential metabolomics-based biomarkers.\"}]","Associations between blood metabolite levels and gastrointestinal cancer risk: A preliminary untargeted metabolomics study | PDF",1790172183,[149,153,157,161],{"page_no":22,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8bfcf40fffb732d9cb316eccf77d653.webp",983,1390,{"page_no":26,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d4805bf850ccca856f4f0617f4344e4.webp",982,1389,{"page_no":30,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa286a0e81193eba27d3aa8b832b74a4.webp",981,1387,{"page_no":33,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be5f4e790c4b8ab09c447143ec031513.webp",980,1386]